Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease
Molecules · 03.03.2023 · 28 (5) · 2336
DOI: 10.3390/molecules28052336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 03.03.2023. Verfasst von Xinyu Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry & Chemical Engineering, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the National Natural Science Foundation of China (82174007), National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is to blame for about 60% of dementia cases worldwide. The blood–brain barrier (BBB) prevents many medications for AD from having clinical therapeutic effects that can be used to treat the affected area. Many researchers have turned their attention to cell membrane biomimetic nanoparticles (NPs) to solve this situation. Among them, NPs can extend the half-life of drugs in the body as the “core” of the wrapped drug, and the cell membrane acts as the “shell” of the wrapped NPs to functionalize the NPs, which can further improve the delivery efficiency of nano-drug delivery systems. Researchers are learning that cell membrane biomimetic NPs can circumvent the BBB’s restriction, prevent harm to the body’s immune system, extend the period that NPs spend in circulation, and have good biocompatibility and cytotoxicity, which increases efficacy of drug release. This review summarized the detailed production process and features of core NPs and further introduced the extraction methods of cell membrane and fusion methods of cell membrane biomimetic NPs. In addition, the targeting peptides for modifying biomimetic NPs to target the BBB to demonstrate the broad prospects of cell membrane biomimetic NPs drug delivery systems were summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemistry & Chemical Engineering, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China.
- College of Jiamusi, Heilongjiang University of Chinese Medicine, Harbin 150004, China.
- Wuxi Traditional Chinese Medicine Hospital, Wuxi 214071, China.
- Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
ORCID-Profile: Ning Zhang
Förderung
- This work was supported by the National Natural Science Foundation of China (82174007)
- National Natural Science Foundation of China
Zitieren
APA
Zhong, X., Na, Y., Yin, S., Yan, C., Gu, J., Zhang, N., & Geng, F. (2023). Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease. Molecules, 28(5), 2336. https://doi.org/10.3390/molecules28052336
Vancouver
Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, et al. Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease. Molecules. 2023;28(5):2336. doi:10.3390/molecules28052336
BibTeX
@article{Zhong2023,
author = {Zhong, Xinyu and Na, Yue and Yin, Shun and Yan, Chang and Gu, Jinlian and Zhang, Ning and Geng, Fang},
title = {Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease},
journal = {Molecules},
year = {2023},
volume = {28},
number = {5},
pages = {2336},
doi = {10.3390/molecules28052336}
}
EUVIMED